glutathione disulfide has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Day, BJ; Fulton, R; Huang, J; Liang, LP; Patel, M | 1 |
1 other study(ies) available for glutathione disulfide and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo.
Topics: Administration, Oral; Animals; Blood-Brain Barrier; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Glutathione; Glutathione Disulfide; Half-Life; Injections, Subcutaneous; Male; Metalloporphyrins; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2007 |